Vitamin D: Potential in the Prevention and Treatment of Lung Cancer

被引:0
作者
Norton, Rosemary [1 ]
O'Connell, Maria A. [1 ]
机构
[1] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England
关键词
Vitamin D; lung cancer; inflammation; review; chronic obstructive pulmonary disease; VDR; calcidiol; OBSTRUCTIVE PULMONARY-DISEASE; SERUM 25-HYDROXYVITAMIN D; TUMOR-BEARING MICE; D-RECEPTOR; RETINOIC ACID; 1-ALPHA; 25-DIHYDROXYVITAMIN D-3; 1,25-DIHYDROXYVITAMIN D-3; DOWN-REGULATION; ALL-TRANS; CELL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vitamin D is a steroid hormone traditionally recognized for maintaining calcium and phosphorous homeostasis in the body. However, it is now widely accepted that it exerts several extraskeletal actions, including anti-tumorigenic and immunomodulatory effects in vitro and in vivo. There is now a huge interest in studying the modes of action of vitamin D in a wide range of infectious and chronic disease settings and its potential in cancer prevention and treatment is currently under detailed investigation. In relation to the lung, evidence from observational studies, animal models and in vitro cell culture suggest that vitamin D may play a beneficial role in pulmonary inflammation. In addition, an adequate vitamin D status may be important for lung cancer prevention. Furthermore, vitamin D or its analogs, alone or in combination with cytotoxics, have potential in the treatment of lung cancer. Vitamin D is converted to its active form locally in the lung, suggesting that it may play an important role in lung health. Here, we review the evidence from observational, clinical and experimental studies in relation to vitamin D and lung cancer. In addition, we discuss vitamin D resistance in lung tumors and the potential molecular mechanisms of vitamin D action in lung cancer cells.
引用
收藏
页码:211 / 221
页数:11
相关论文
共 90 条
[1]   Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity [J].
Adams, John S. ;
Hewison, Martin .
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (02) :80-90
[2]   Chronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights [J].
Adcock, Ian M. ;
Caramori, Gaetano ;
Barnes, Peter J. .
RESPIRATION, 2011, 81 (04) :265-284
[3]   Epidemiology of lung cancer - ACCP evidence-based clinical practice guidelines (2nd edition) [J].
Alberg, Anthony J. ;
Ford, Jean G. ;
Samet, Jonathan M. .
CHEST, 2007, 132 (03) :29S-55S
[4]   Expression of VDR and CYP24A1 mRNA in human tumors [J].
Anderson, MG ;
Nakane, M ;
Ruan, XA ;
Kroeger, PE ;
Wu-Wong, JR .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (02) :234-240
[5]  
[Anonymous], 2010, AGE AGEING, DOI DOI 10.1093/ageing/afp195
[6]   Vitamin D2 is much less effective than vitamin D3 in humans [J].
Armas, LAG ;
Hollis, BW ;
Heaney, RP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11) :5387-5391
[7]   1,25-Dihydroxyvitamin D3 and PI3K/AKT Inhibitors Synergistically Inhibit Growth and Induce Senescence in Prostate Cancer Cells [J].
Axanova, Linara S. ;
Chen, Yong Q. ;
McCoy, Thomas ;
Sui, Guangchao ;
Cramer, Scott D. .
PROSTATE, 2010, 70 (15) :1658-1671
[8]  
Brody Jerome S, 2006, Proc Am Thorac Soc, V3, P535, DOI 10.1513/pats.200603-089MS
[9]   CYP24A1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma [J].
Chen, Guoan ;
Kim, So Hee ;
King, Amanda N. ;
Zhao, Lili ;
Simpson, Robert U. ;
Christensen, Paul J. ;
Wang, Zhuwen ;
Thomas, Dafydd G. ;
Giordano, Thomas J. ;
Lin, Lin ;
Brenner, Dean E. ;
Beer, David G. ;
Ramnath, Nithya .
CLINICAL CANCER RESEARCH, 2011, 17 (04) :817-826
[10]  
Collins LG, 2007, AM FAM PHYSICIAN, V75, P56